The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.
Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults
Abstract
Purpose To assess the efficacy, dose stability, safety, and abuse potential of long-term, nightly benzodiazepine treatment of chronic disorders of disrupted nocturnal sleep.Patients and methods During a 12-year period, one author evaluated and treated 170 adult referrals for > or = 6 months with nightly benzodiazepine therapy for longstanding, sleep-disruptive disorders: injurious sleepwalking and sleep terrors (69); rapid eye movement sleep behavior disorder (52); chronic, severe insomnia (25); and restless legs syndrome/periodic limb movement disorder (24).Results Complete/substantial control of the sleep disorders was achieved by 146 patients (86%); 8% had adverse effects requiring medication changes; 2% had relapses of alcohol or chemical abuse requiring hospitalization; another 2% at times misused their medications. A total of 136 patients received clonazepam nightly for a mean 3.5 (+/- 2.4) years, with no significant difference in inital versus final mean dose: 0.77 mg (+/- 0.46) versus 1.10 mg (+/- 0.96). Similar results were obtained with chronic alprazolam treatment and with other benzodiazepine treatments.Conclusion Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep resulted in sustained efficacy in most cases, with low risk of dosage tolerance, adverse effects, or abuse. Data from this study on the treatment of chronic, severe insomnia (a small subset of all insomnia) are not generalizable to the typical insomnia patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a larger case series published in 1996 on 58 patients with SW and ST demonstrated the efficacy, dose stability, safety, and low abuse potential of chronic, nightly, low/moderate doses of Clonazepam [100].”
From Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults (2023) · cites this paper as [100]
In the citing paper
“The efficacy of Clonazepam has also been occasionally described in some cases of DoA induced by neuroleptics [102] and in cases of sleep-driving and violent behaviors [16,100].”
From Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults (2023) · cites this paper as [100]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
Principles and Practice of Sleep Medicine
(2011) · Elsevier eBooks · doi:10.1016/c2009-0-59875-3 · Cited by 5,088
The International Classification of Sleep Disorders: Diagnostic and Coding Manual
Daroff, R. B. (1991) · Neurology · doi:10.1212/wnl.41.1.160 · Cited by 5,014
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,799
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.979 · Cited by 1,485
Principles and practice of sleep medicine
Sloan, E. P. (1995) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(95)90167-1 · Cited by 1,389
A manual of Standardized Terminology
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 632
Benzodiazepines: use, abuse, and consequences.
Woods, J. H., Katz, J. L., & Winger, G. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00468-5 · Cited by 560
Cited by
Mollayeva, T., Thurairajah, P., Burton, K., Mollayeva, S., Shapiro, C. M., & Colantonio, A. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.01.009 · Cited by 1,847
Olson, E. J., Boeve, B. F., & Silber, M. H. (2000) · Brain · doi:10.1093/brain/123.2.331 · Cited by 895
“Although the general safety of clonazepam use has been demonstrated in a population of patients with sleep disorders (Schenck and Mahowald, 1996b), benzodiazepines may result in confusion or falls in elderly patients with neurodegenerative diseases (Woods and Winger, 1995), or may worsen…”
BackgroundResultInfluentialSchenck, C. H., & Mahowald, M. W. (2002) · SLEEP · doi:10.1093/sleep/25.2.120 · Cited by 770
Self-citationBoeve, B. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05115.x · Cited by 643
Wilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
“Clonazepam in doses up to 3mg per night has been reported to be effective (case series, n1⁄4 69) (Schenck and Mahowald, 1996).”
Background
Metadata
- Authors
- Schenck, C. H., & Mahowald, M. W.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Schenck, Carlos H.
- ORCID
- Schenck, Carlos H.
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 1996-03
- Volume
- 100
- Issue
- 3
- Pages
- 333-337
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W2084759069
- Cited by
- 291
- References
- 32
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 7 · 2022: 18 · 2021: 8 · 2020: 9 · 2019: 9 · 2018: 16 · 2017: 16 · 2016: 11 · 2015: 8 · 2014: 9 · 2013: 15 · 2012: 13
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Clinical Neurology › Restless Legs Syndrome Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- benzodiazepines, sleepwalking, sleep terrors, REM sleep behavior disorder, chronic insomnia, restless legs syndrome, periodic limb movement disorder, clonazepam, alprazolam, dose stability, medication abuse, adverse effects, treatment efficacy
- MeSH terms
- Adult, Alprazolam, Chronic Disease, Clonazepam, Drug Administration Schedule, Female, Humans, Sleep Initiation and Maintenance Disorders, Male, Restless Legs Syndrome, Sleep Wake Disorders, Somnambulism, Anti-Anxiety Agents, Treatment Outcome, Polysomnography, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. https://app.cochat.ai/papers/10.1016/s0002-9343(97)89493-4
- The paper
- Schenck, C. H., & Mahowald, M. W. (1996). Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. The American Journal of Medicine. https://doi.org/10.1016/s0002-9343(97)89493-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.